Eosinophilic Gasteroenteritis (EG)
What is eosinophilic gasteroenteritis?
Eosinophilic gastrointeritis is a form of eosinophilic enteropothy affecting the stomach and small intestine. Eosinophilic enteropothy causes a buildup of toxin releasing white blood cells (eosinophils) that are normally part of the body’s immune response. The specific type of enteropothy (such as gastroenteritis) is determined by the area of the gastrointestinal tract affected. The increase in eosinophils leads to polyps, tissue break down, inflammation, and ulcers. Other names for eosinophilic gastrointeritis include EG, EGE, EGID, eosinophilic gastritis, eosinophilic gastroenteropathy, and eosinophilic gastrointestinal disorders.What are the symptoms of eosinophilic gasteroenteritis?
Symptoms of EG can include:- heartburn
- skin rash
- acid reflux
- anemia
- diarrhea
- stomach cramps
- bleeding
- vomiting
- loss of appetite
- blood loss in stools
- bloating (with possible ascites)
- dysphagia
What causes eosinophilic gasteroenteritis?
The exact causes of EG remain unknown. There is evidence to suggest that it is caused, in some cases, by hypersensitivty to certain food or allergens. Commonly, a family history of allergy presents alongside EG. EG is slightly more common in men. EG most often occurs between the ages of 20 and 50. Preexisting asthma, allergy, and eczema seem to increase risk.How is eosinophilic gasteroenteritis diagnosed?
Biopsy and endoscopy are currently the only ways to diagnose EG.What are the treatments for eosinophilic gasteroenteritis?
Though no complete cure currently exists for EG, treatment of symptoms can greatly improve the condition of patients and prevent further damage. Strict regulation of diet can ease some symptoms. Certain corticosteroids may be helpful in treatment. Immunosuppresive drugs can also be helpful. In cases where the intestines are obstructed surgery may be necessary.Where can I find out more about eosinophilic gasteroenteritis?
Eosinophilic Gasteroenteritis (EG) Articles
EP-104GI Performs Well in Eosinophilic Esophagitis (EoE) Trial
Jessica Lynn
June 11, 2024
Read More »
Eosinophilic Esophagitis Patients Are Seeing Improved Treatment Options
James Moore
April 11, 2024
Read More »
Dupixent Label Expands to Include Children Ages 1-11 with Eosinophilic Esophagitis
Jessica Lynn
February 14, 2024
Read More »
FDA Gives Approval to EOHILIA for Eosinophilic Esophagitis (EoE)
Patient Worthy Contributor
February 14, 2024
Read More »
Research Suggests That Maternal and Infant Antibiotic Exposure Heightens EoE Risk
Jessica Lynn
December 11, 2023
Read More »
Priority Review Granted to Dupixent sBLA for EoE in Children Ages 1-11
Jessica Lynn
October 10, 2023
Read More »
After a 26-year Journey, I Created My Own Diet and Healed My Eosinophilic Esophagitis (EoE)
Miriam Diaz-Gilbert
September 25, 2023
Read More »
Phase 2 Eosinophilic Esophagitis Trial Completes Recruitment
James Moore
September 13, 2023
Read More »